KLI
PGEN icon

Kelman-Lazarov Inc’s Precigen PGEN Stock Holding History

Kelman-Lazarov Inc’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,110
Closed -$31.7K – 345
2016
Q3 		$31.7K Hold
1,110
– – 0.02% 212
2016
Q2 		$29K Hold
1,110
– – 0.02% 208
2016
Q1 		$38K Buy
+1,110
New +$34.9K 0.02% 200

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Kelman-Lazarov Inc's PGEN Position: Q4 2016 in Review

Kelman-Lazarov Inc sold out of Precigen (PGEN) in Q4 2016, closing a stake of 1,110 shares — an estimated $31.7K sold.

Kelman-Lazarov Inc first reported a position in PGEN in Q1 2016 and held it in 3 quarters. The position peaked at $38K in Q1 2016. 171 funds tracked by Wall St. Rank hold PGEN as of Q4 2016.

  • Kelman-Lazarov Inc reported no remaining Precigen position as of Q4 2016 after selling out during the quarter.
  • Kelman-Lazarov Inc sold 1,110 Precigen shares in Q4 2016, an estimated $31.7K.
  • Kelman-Lazarov Inc first reported a position in Precigen in Q1 2016 and held it in 3 quarters.
  • Kelman-Lazarov Inc's Precigen position peaked at $38K in Q1 2016.
  • 171 funds tracked by Wall St. Rank held Precigen as of Q4 2016.

Based on Kelman-Lazarov Inc's 13F filing for Q4 2016, filed 17 Jan 2017.